Seeking Alpha

NPS Pharmaceuticals (NPSP -3.7%) gives back all its premarket gains and more, despite the...

NPS Pharmaceuticals (NPSP -3.7%) gives back all its premarket gains and more, despite the postive Phase 3 results for its hypoparathyroid treatment earlier today. The company has been on a steady downtrend for most of this year, losing nearly 50% since hitting a 52-week high in May.
From other sites
Comments (1)
  • Christopher Nassar
    , contributor
    Comments (6) | Send Message
     
    NPSP seems like a very good buy at this point. It doesn't seem to have anywhere to go but up. The market can of course be tricky but I see a 90% chance of making a profit here.
    8 Nov 2011, 07:47 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs